Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Hofer

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Mediators of Inflammation|February 28, 2020
The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection FractionAndreas Hammer, Patrick Sulzgruber, Lorenz Koller, et al.
Thrombosis and Haemostasis|November 12, 2021
The Prognostic Potential of Growth Differentiation Factor-15 on Bleeding Events and Patient Outcome after Cardiac Surgery-A Prospective Cohort StudyNiema Kazem, Andreas Hammer, Lorenz Koller, et al.
European Journal of Clinical Investigation|November 20, 2020
The impact of volume substitution on post-operative atrial fibrillationSebastian Schnaubelt, Arnold Pilz, Lorenz Koller, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 24, 2023
Prescribing trends of sodium-glucose cotransporter 2 inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fractionFelix Hofer, Andreas Hammer, Eva Steinacher, et al.
Cardiovascular Drugs and Therapy|August 3, 2021
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart FailureFelix Hofer, Niema Kazem, Bernhard Richter, et al.
Cardiovascular Drugs and Therapy|September 10, 2021
The Prognostic Impact of Anti-thrombotic Treatment Strategies After Biological Aortic Valve ReplacementAndreas Hammer, Felix Hofer, Niema Kazem, et al.
JACC. Advances|October 15, 2025
Routinely Available Inflammatory Biomarkers Are Not Associated With Target Lesion Revascularization After Coronary InterventionEva Steinacher, Andreas Hammer, Ulrike Baumer, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 10, 2022
The impact of left atrial mechanics on adverse events and clinical outcome after cardiac surgeryDaniel Dalos, Sophie Selina Haaser, Felix Hofer, et al.
Journal of Personalized Medicine|February 25, 2025
Mid-Regional Pro-Adrenomedullin Is Associated with Adverse Cardiovascular Outcomes After Cardiac SurgeryUlrike Baumer, Niema Kazem, Andreas Hammer, et al.
Scientific Reports|September 24, 2020
Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studiesMax-Paul Winter, Philipp Bartko, Felix Hofer, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Mediators of Inflammation|February 28, 2020
The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection FractionAndreas Hammer, Patrick Sulzgruber, Lorenz Koller, et al.
Thrombosis and Haemostasis|November 12, 2021
The Prognostic Potential of Growth Differentiation Factor-15 on Bleeding Events and Patient Outcome after Cardiac Surgery-A Prospective Cohort StudyNiema Kazem, Andreas Hammer, Lorenz Koller, et al.
European Journal of Clinical Investigation|November 20, 2020
The impact of volume substitution on post-operative atrial fibrillationSebastian Schnaubelt, Arnold Pilz, Lorenz Koller, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 24, 2023
Prescribing trends of sodium-glucose cotransporter 2 inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fractionFelix Hofer, Andreas Hammer, Eva Steinacher, et al.
Cardiovascular Drugs and Therapy|August 3, 2021
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart FailureFelix Hofer, Niema Kazem, Bernhard Richter, et al.
Cardiovascular Drugs and Therapy|September 10, 2021
The Prognostic Impact of Anti-thrombotic Treatment Strategies After Biological Aortic Valve ReplacementAndreas Hammer, Felix Hofer, Niema Kazem, et al.
JACC. Advances|October 15, 2025
Routinely Available Inflammatory Biomarkers Are Not Associated With Target Lesion Revascularization After Coronary InterventionEva Steinacher, Andreas Hammer, Ulrike Baumer, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 10, 2022
The impact of left atrial mechanics on adverse events and clinical outcome after cardiac surgeryDaniel Dalos, Sophie Selina Haaser, Felix Hofer, et al.
Journal of Personalized Medicine|February 25, 2025
Mid-Regional Pro-Adrenomedullin Is Associated with Adverse Cardiovascular Outcomes After Cardiac SurgeryUlrike Baumer, Niema Kazem, Andreas Hammer, et al.
Scientific Reports|September 24, 2020
Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studiesMax-Paul Winter, Philipp Bartko, Felix Hofer, et al.
Pageof 5